Study of the Signal Transduction of and Cellular Response (Growth Stimulation and Cytotoxicity) to Tumor Necrosis Factor
Study of the Signal Transduction of and Cellular Response (Growth Stimulation and Cytotoxicity) to Tumor Necrosis Factor
批准号:
02671023
负责人:
OKU Naoto
金额:
$1.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1990
资助国家:
日本
项目状态:
已结题
起止时间:
1990 至 1991
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Tumor Necrosis Factor (TNF) exerts cytotoxic and cytostatic action against certain tumor cells while sparing normal cells both in vitro and in vivo. TNF is thought to have both growth stimulatory and inhibitory signals. We discovered that human diploid fibroblast FS-4 cells, which growth was stimulated by TNF, generated prostaglandin that suppressed cell growth. By the analysis of prostaglandins, PGE_2 was the main prostaglandin produced in FS-4 cells and the production of this prostaglandin was stimulated by TNF-treatment. Furthermore, when prostaglandin production was enhanced by the addition of arachidonate, TNF acts as cytotoxic factor against FS-4 cells. For elucidating the early event of TNF-signal transduction, TNF receptor was purified by TNF-affinity chromatograpy was examined. TNF receptor was a molecular assembly of 300 kDa, including G-protein. Therefore, TNF-signal might stimulate phospholipase A_2 via G-protein, then released arachidonate might convert to prostaglandins. Next, the involvement of prostaglandins in the cytotoxic action of TNF was examined using TNF-sensitive L929 cells and TNF-resistant sublines. L929 cells generated prostaglandin by the treatment of TNF, whereas TNF-resistant sublines did not. Furthermore the cytotoxic action of TNF on L929 cells was inhibited by the addition of indomethacin, suggesting that prostaglandin may be involved in the cytotoxic action of TNF. These results indicate the involvement of prostaglandinproducing pathway in the cytotoxic action of TNF.
期刊论文(17)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Makio Hayakawa, Naoto Oku, Tatsuya Takagi, Tatamitus Hori, Sayumi Shibamoto, Yoichi Yamanaka, Kenji Takeuchi, Masafumi Tsujimoto and Fumiaki Ito: ""Involvement of Prostaglandin-Producing Pathway in the Cytotoxic Action of Tumor Necrosis Factor. "" Cell St
Makio Hayakawa、Naoto Oku、Tatsuya Takagi、Tatamitus Hori、Sayumi Shibamoto、Yoichi Yamanaka、Kenji Takeuchi、Masafumi Tsujimoto 和 Fumiaki Ito:“前列腺素生成途径参与肿瘤坏死因子的细胞毒性作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takamitsu Hori: "Growth Inhibition of Human Fibroblasts by Epidermal Growth Factor in the Presence of Arachidonic Acid" Biochem.Biophys.Res.Commun.169. 959-965 (1990)
Takamitsu Hori:“花生四烯酸存在下表皮生长因子对人类成纤维细胞的生长抑制”Biochem.Biophys.Res.Commun.169。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Takamitsu Hori, Yoichi Yamanaka, Makio Hayakawa, Sayumi Shibamoto, Masafumi Tsujimoto, Naoto Oku and Fumiaki Ito: ""Prostaglandins Antagonize Fibroblast Proliferation Stimulated by Tumor Necrosis Factor. "" Biochem. Biophys. Res. Commun.174. 758-766 (1991
Takamitsu Hori、Yoichi Yamanaka、Makio Hayakawa、Sayumi Shibamoto、Masafumi Tsujimoto、Naoto Oku 和 Fumiaki Ito:“前列腺素拮抗肿瘤坏死因子刺激的成纤维细胞增殖。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Makio Hayakawa: "Involvement of Prostaglandinーproducing Pathway in the Cytotoxic Action of Tumor Necrosis Factor" Cell Struct.Funct.16. 333-340 (1991)
Makio Hayakawa:“前列腺素生成途径参与肿瘤坏死因子的细胞毒性作用”Cell Struct.Funct.16(1991)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Makio Hayakawa: "Involvement of Prostaglandin-producing Pathway in the Cytotoxic Action of Tumor Necrosis Factor" Cell Struct.Funct.16. 333-340 (1991)
Makio Hayakawa:“前列腺素生成途径参与肿瘤坏死因子的细胞毒作用”Cell Struct.Funct.16。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 13 条
Development of FA-Snap, a smart DDS drug, for proposing an innovative therapeutic modality of ischemic stroke.
-
批准号:16H05081
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.65万
-
财政年份:2016
-
负责人:OKU Naoto
-
依托单位:
New development of diagnostic and therapeutic modality for ischemia/reperfusion injury by intelligent DDS
-
批准号:23249005
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$30.7万
-
财政年份:2011
-
负责人:OKU Naoto
-
依托单位:
Development of novel nanoparticles for DDS, and establishment of Therapeutic modality for brain ischemia by use of these nanoparticles.
-
批准号:22659010
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$1.98万
-
财政年份:2010
-
负责人:OKU Naoto
-
依托单位:
A novel targeting DDS for the treatment of autoimmune diseases and allergy
-
批准号:20390014
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.4万
-
财政年份:2008
-
负责人:OKU Naoto
-
依托单位:
Development of Radical Treatment Modality for Curing Allergies and Immune Diseases by a Novel Consept, RTDDS
-
批准号:18390052
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.0万
-
财政年份:2006
-
负责人:OKU Naoto
-
依托单位:
Establishment of Antineovascular Therapy by use of Structure-recognizing targeting probes
-
批准号:15390050
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.66万
-
财政年份:2003
-
负责人:OKU Naoto
-
依托单位:
Angiogenesis Suppression and Cancer Treatment by Use of Neovascular Targeted Probe
-
批准号:12470507
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.09万
-
财政年份:2000
-
负责人:OKU Naoto
-
依托单位:
Non-invasive in vivo analysis of early metastatic processes
-
批准号:09470506
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.62万
-
财政年份:1997
-
负责人:OKU Naoto
-
依托单位:
Cancer Photodynamic Therapy by use of RES-avoiding Liposomes
-
批准号:07672424
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:OKU Naoto
-
依托单位:
DEVELOPMENT OF FUNCTIONAL RES-AVOIDING LIPOSOMES AND THEIR USE IN CANCER THERAPY
-
批准号:05671874
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1993
-
负责人:OKU Naoto
-
依托单位:
国内基金
海外基金
登录
查看更多内容
早期滋养型肠内营养联合益生菌对重症卒中患者喂养耐受性及TNF-α/IL-6水平的影响研究
-
批准号:2026JJ81631
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:廖思思
-
依托单位:
FMR1基因通过TNF信号通路在下颌骨-髂骨移植微环境中对破骨细胞分化及骨整合的调控机制
-
批准号:JCZRLH202600476
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
肿瘤坏死因子(TNFα)配对检测抗体的研发
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:吉敬
-
依托单位:
自噬相关基因CCl2在颅脑创伤(TBI)中通过TNF信号通路导致神经元损伤的机制研究
-
批准号:2026JJ82489
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:贾哲勇
-
依托单位:
基于免疫微环境调控的ICIs治疗恶性肿瘤患者结核病风险机制及 TNF-α/INF-γ调控机制研究
-
批准号:JCZRLH202601148
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
早产儿脑白质损伤的 MRI 影像学特征联合炎症因子组合(IL-6、TNF-α、IL-1β)与神经系统损害关联研究
-
批准号:JCZRLH202601761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
炎症因子组合(IL-6、TNF-α、IL-1β)动态监测在极低出生体重儿坏死性小肠结肠炎早期预测中的价值研究
-
批准号:JCZRLH202601488
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
龙胆酸A靶向TNF-α调控NF-κB/NLRP3炎性小体减轻肝纤维化的机制研究
-
批准号:2026JJ80905
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:彭江丽
-
依托单位:
葛根素通过抑制巨噬细胞TNF/NFKB通路发挥抗动脉粥样硬化的作用
-
批准号:2026JJ80326
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:简武
-
依托单位:
红紫素-锰基免疫刺激剂放大ROS及调控STING/TNF-α通路增强黑色素瘤免疫治疗机制研究
-
批准号:2026JJ60558
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈安琪
-
依托单位: